Curaleaf Holdings (CURLF) Receivables - Net (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Receivables - Net of $76.3 million for Q4 2025, up 19.3% year-on-year from $64.0 million in Q4 2024, and up 19.3% on a QoQ basis from $64.0 million in Q4 2024.
Curaleaf Holdings (CURLF) Receivables - Net (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Receivables - Net for 7 consecutive years, with $76.3 million the latest figure, recorded in Q4 2025.
- Quarterly Receivables - Net rose 19.3% year-over-year to $76.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $76.3 million (up 19.3% YoY) and the FY2025 annual result came in at $76.3 million, up 15.61% from the prior year.
- Receivables - Net rose to $76.3 million in Q4 2025 per CURLF's latest filing, from $64.0 million in the prior quarter.
- Over the last five years, Receivables - Net for CURLF reached as high as $66.8 billion in Q1 2022 and fell as low as $33.8 million in Q1 2021.
- A 5-year average of $5.2 billion and a median of $60.0 million in 2023 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2022 — Receivables - Net jumped 197852.59% — and 2023, when it slumped 37.92%.
- Year by year, Receivables - Net stood at $60.4 million in 2021, then dropped by 25.23% to $45.2 million in 2022, then soared by 32.8% to $60.0 million in 2023, then advanced by 6.65% to $64.0 million in 2024, then grew by 19.3% to $76.3 million in 2025.
- According to Business Quant data, Receivables - Net over the past three periods registered $76.3 million, $64.0 million, and $60.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.34 Mn |
| Dec 31, 2025 | 76.34 Mn |
| Dec 31, 2024 | 63.99 Mn |
| Dec 31, 2024 | 63.99 Mn |
| Dec 31, 2023 | 60.00 Mn |
| Dec 31, 2023 | 60.00 Mn |
| Sep 30, 2023 | 38.06 Mn |
| Sep 30, 2023 | 38.06 Mn |
| Jun 30, 2023 | 46.67 Mn |
| Jun 30, 2023 | 46.67 Mn |
| Dec 31, 2022 | 45.18 Mn |
| Dec 31, 2022 | 45.18 Mn |
| Sep 30, 2022 | 61.31 Mn |
| Sep 30, 2022 | 61.31 Mn |
| Jun 30, 2022 | 64.65 Mn |
| Jun 30, 2022 | 64.65 Mn |
| Mar 31, 2022 | 66.81 Bn |
| Mar 31, 2022 | 66.81 Bn |
| Dec 31, 2021 | 60.43 Mn |
| Dec 31, 2021 | 60.43 Mn |